Literature DB >> 8741839

Isolation and characterization of p19INK4d, a p16-related inhibitor specific to CDK6 and CDK4.

K L Guan1, C W Jenkins, Y Li, C L O'Keefe, S Noh, X Wu, M Zariwala, A G Matera, Y Xiong.   

Abstract

Cyclin-dependent kinases 4 and 6 are complexed with many small cellular proteins in vivo. We have isolated cDNA sequences, INK4d, encoding a 19-kDa protein that is associated with CDK6 in several hematopoietic cell lines. p19 shares equal similarity and a common ancestor with other identified inhibitors of the p16/INK4 family. p19 interacts with and inhibits the activity of both CDK4 and CDK6 and exhibits no detectable interaction with the other known CDKs. p19 protein is present in both cell nuclei and cytoplasm. The p19 gene has been mapped to chromosome 19p13.2, and the level of its mRNA expression varies widely between different tissues. In contrast to p21 and p27 whose interaction with CDK subunits is dependent on or stimulated by the cyclin subunit, the interaction of p19 and p18 with CDK6 is hindered by the cyclin protein. Binary cyclin D1-p18/p19 or cyclin D1-CDK6 complexes are highly stable and cannot be dissociated by excess amounts of cyclin D1 or p19/p18 proteins, suggesting that p16 inhibitors and D cyclins may interact with CDKs 4 and 6 in a competing or potentially mutually exclusive manner.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8741839      PMCID: PMC278612          DOI: 10.1091/mbc.7.1.57

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  40 in total

Review 1.  G1 phase progression: cycling on cue.

Authors:  C J Sherr
Journal:  Cell       Date:  1994-11-18       Impact factor: 41.582

Review 2.  Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age.

Authors:  T Hunter; J Pines
Journal:  Cell       Date:  1994-11-18       Impact factor: 41.582

3.  Cyclin D1 is a nuclear protein required for cell cycle progression in G1.

Authors:  V Baldin; J Lukas; M J Marcote; M Pagano; G Draetta
Journal:  Genes Dev       Date:  1993-05       Impact factor: 11.361

4.  D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA.

Authors:  Y Xiong; H Zhang; D Beach
Journal:  Cell       Date:  1992-10-30       Impact factor: 41.582

5.  Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase.

Authors:  K L Guan; J E Dixon
Journal:  Anal Biochem       Date:  1991-02-01       Impact factor: 3.365

6.  Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme.

Authors:  H Flores-Rozas; Z Kelman; F B Dean; Z Q Pan; J W Harper; S J Elledge; M O'Donnell; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

Review 7.  Cytogenetic heterogeneity in t(11;19) acute leukemia: clinical, hematological and cytogenetic analyses of 48 patients--updated published cases and 16 new observations.

Authors:  J L Huret; A Brizard; R Slater; C Charrin; M F Bertheas; F Guilhot; K Hählen; W Kroes; E van Leeuwen; E V Schoot
Journal:  Leukemia       Date:  1993-02       Impact factor: 11.528

8.  Recurrent cytogenetic aberrations and loss of constitutional heterozygosity in ovarian carcinomas.

Authors:  M Kiechle-Schwarz; T Bauknecht; U Karck; F Kommoss; A du Bois; A Pfleiderer
Journal:  Gynecol Oncol       Date:  1994-11       Impact factor: 5.482

9.  Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation.

Authors:  J Y Kato; M Matsuoka; K Polyak; J Massagué; C J Sherr
Journal:  Cell       Date:  1994-11-04       Impact factor: 41.582

10.  Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase.

Authors:  O Aprelikova; Y Xiong; E T Liu
Journal:  J Biol Chem       Date:  1995-08-04       Impact factor: 5.157

View more
  26 in total

Review 1.  Integration of the pRB and p53 cell cycle control pathways.

Authors:  C L Stewart; A M Soria; P A Hamel
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

Review 2.  Utilizing NMR to study the structure of growth-inhibitory proteins.

Authors:  Francesca Marassi
Journal:  Methods Mol Biol       Date:  2003

Review 3.  Targeting CDK6 in cancer: State of the art and new insights.

Authors:  Solomon Tadesse; Mingfeng Yu; Malika Kumarasiri; Bich Thuy Le; Shudong Wang
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  p19(INK4d) mRNA and protein expression as new prognostic factors in ovarian cancer patients.

Authors:  Anna Felisiak-Golabek; Agnieszka Dansonka-Mieszkowska; Iwona K Rzepecka; Lukasz Szafron; Ewa Kwiatkowska; Bozena Konopka; Agnieszka Podgorska; Alina Rembiszewska; Jolanta Kupryjanczyk
Journal:  Cancer Biol Ther       Date:  2013-08-14       Impact factor: 4.742

5.  Genetic and biochemical interactions among Yar1, Ltv1 and Rps3 define novel links between environmental stress and ribosome biogenesis in Saccharomyces cerevisiae.

Authors:  Jesse W Loar; Robert M Seiser; Alexandra E Sundberg; Holly J Sagerson; Nasreen Ilias; Pamela Zobel-Thropp; Elizabeth A Craig; Deborah E Lycan
Journal:  Genetics       Date:  2004-12       Impact factor: 4.562

6.  Pneumocystis carinii inhibits cyclin-dependent kinase activity in lung epithelial cells.

Authors:  A H Limper; M Edens; R A Anders; E B Leof
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

7.  Regulation of CDK4 activity by a novel CDK4-binding protein, p34(SEI-1).

Authors:  M Sugimoto; T Nakamura; N Ohtani; L Hampson; I N Hampson; A Shimamoto; Y Furuichi; K Okumura; S Niwa; Y Taya; E Hara
Journal:  Genes Dev       Date:  1999-11-15       Impact factor: 11.361

8.  Induction of p18INK4c and its predominant association with CDK4 and CDK6 during myogenic differentiation.

Authors:  D S Franklin; Y Xiong
Journal:  Mol Biol Cell       Date:  1996-10       Impact factor: 4.138

9.  Cooperation of p27(Kip1) and p18(INK4c) in progestin-mediated cell cycle arrest in T-47D breast cancer cells.

Authors:  A Swarbrick; C S Lee; R L Sutherland; E A Musgrove
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

10.  Laforin negatively regulates cell cycle progression through glycogen synthase kinase 3beta-dependent mechanisms.

Authors:  Runhua Liu; Lizhong Wang; Chong Chen; Yan Liu; Penghui Zhou; Yin Wang; Xirui Wang; Julie Turnbull; Berge A Minassian; Yang Liu; Pan Zheng
Journal:  Mol Cell Biol       Date:  2008-09-29       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.